Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
NCT: NCT07768631 · NOT_YET_RECRUITING
Brief Summary
This is a prospective, multicenter, randomized, double-blind, sham-controlled, adaptive study evaluating the pulsENDO system in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications (GLMs). The primary objective of this study is to demonstrate that pulsENDO therapy is superior to sham control for improving glycemic control in adults with type 2 diabetes.
Frequently Asked Questions
What is Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes?
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes is a clinical trial registered under NCT07768631. Current status: NOT_YET_RECRUITING.
What is the status of NCT07768631?
The current status of NCT07768631 (Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes) is: NOT_YET_RECRUITING.
When did Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes start?
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes started on 2027-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.